British regulator 1st to OK Moderna's updated COVID booster
British drug regulators have become the first in the world to authorize an updated version of Moderna’s coronavirus vaccine that includes protection against the omicron variant, which the government said would now be offered to people aged 50 and over in the fall.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/H2BUCIN2SJHODCC7CKLMF4ZZ5E.jpg)
Vaccine deliveries rising as delta virus variant slams Asia
As many Asian countries battle their worst surge of COVID-19 infections, the slow flow of vaccine doses from around the world is finally picking up speed, giving hope that inoculation rates can increase and help blunt the effect of the rapidly spreading delta variant.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65):fill(FFF)/cloudfront-us-east-1.images.arcpublishing.com/gmg/HBV3EECS5ZHGJGCJSWYFSCKXDQ.jpg)
The Latest: Australia official urges against AstraZeneca
The top health official in Australia's Queensland state is advising adults under age 40 not to take the AstraZeneca coronavirus vaccine because of the risk of a rare blood clotting disorder, even though the Australian government is making those shots available to all adults.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/d1vhqlrjc8h82r.cloudfront.net/04-27-2021/t_38d912fa100a473a835ccfd2aeb7f80c_name_image.jpg)
Clinical research group in Jacksonville conducting COVID-19 vaccine trials on children as young as 12
The Jacksonville Center for Clinical Research, which helped Pfizer and Moderna conduct trials for their COVID-19 vaccines for adults and older teenagers, is now shifting its attention toward children under the age of 16.